Bradley Foster & Sargent’s Teladoc Health TDOC Stock Holding History

Bradley Foster & Sargent’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,030	Closed	-$206K	–	384
2020 Q4	$206K	Sell	1,030 -23	-2%	-$4.68K	0.01%	360
2020 Q3	$231K	Buy	+1,053	New	+$223K	0.01%	328
2019 Q4	–	Sell	-3,250	Closed	-$220K	–	366
2019 Q3	$220K	Hold	3,250	–	–	0.01%	326
2019 Q2	$216K	Buy	+3,250	New	+$189K	0.01%	332
2018 Q4	–	Sell	-3,050	Closed	-$263K	–	364
2018 Q3	$263K	Buy	+3,050	New	+$217K	0.01%	332

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $39.8M AUM 27.89% 1-Year Est. Return

Bradley Foster & Sargent's TDOC Position: Q1 2021 in Review

Bradley Foster & Sargent sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 1,030 shares — an estimated $206K sold.

Bradley Foster & Sargent first reported a position in TDOC in Q3 2018 and held it in 5 quarters. The position peaked at $263K in Q3 2018. 890 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

Bradley Foster & Sargent reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
Bradley Foster & Sargent sold 1,030 Teladoc Health shares in Q1 2021, an estimated $206K.
Bradley Foster & Sargent first reported a position in Teladoc Health in Q3 2018 and held it in 5 quarters.
Bradley Foster & Sargent's Teladoc Health position peaked at $263K in Q3 2018.
890 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Bradley Foster & Sargent's 13F filing for Q1 2021, filed 26 Apr 2021.